99 related articles for article (PubMed ID: 24287382)
21. Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activity.
Surivet JP; Lange R; Hubschwerlen C; Keck W; Specklin JL; Ritz D; Bur D; Locher H; Seiler P; Strasser DS; Prade L; Kohl C; Schmitt C; Chapoux G; Ilhan E; Ekambaram N; Athanasiou A; Knezevic A; Sabato D; Chambovey A; Gaertner M; Enderlin M; Boehme M; Sippel V; Wyss P
Bioorg Med Chem Lett; 2012 Nov; 22(21):6705-11. PubMed ID: 23006603
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic assessment of DNA ligase as an antibacterial target in Staphylococcus aureus.
Podos SD; Thanassi JA; Pucci MJ
Antimicrob Agents Chemother; 2012 Aug; 56(8):4095-102. PubMed ID: 22585221
[TBL] [Abstract][Full Text] [Related]
23. Development of a fluorescence resonance energy transfer assay for measuring the activity of Streptococcus pneumoniae DNA ligase, an enzyme essential for DNA replication, repair, and recombination.
Chen XC; Hentz NG; Hubbard F; Meier TI; Sittampalam S; Zhao G
Anal Biochem; 2002 Oct; 309(2):232-40. PubMed ID: 12413456
[TBL] [Abstract][Full Text] [Related]
24. A high-throughput fluorescence resonance energy transfer-based assay for DNA ligase.
Shapiro AB; Eakin AE; Walkup GK; Rivin O
J Biomol Screen; 2011 Jun; 16(5):486-93. PubMed ID: 21398623
[TBL] [Abstract][Full Text] [Related]
25. NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis. Crystal structure of the adenylation domain and identification of novel inhibitors.
Srivastava SK; Tripathi RP; Ramachandran R
J Biol Chem; 2005 Aug; 280(34):30273-81. PubMed ID: 15901723
[TBL] [Abstract][Full Text] [Related]
26. Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Aslfm).
Škedelj V; Perdih A; Brvar M; Kroflič A; Dubbée V; Savage V; O'Neill AJ; Solmajer T; Bešter-Rogač M; Blanot D; Hugonnet JE; Magnet S; Arthur M; Mainardi JL; Stojan J; Zega A
Eur J Med Chem; 2013 Sep; 67():208-20. PubMed ID: 23867605
[TBL] [Abstract][Full Text] [Related]
27. Structure based identification of first-in-class fragment inhibitors that target the NMN pocket of M. tuberculosis NAD
Shukla A; Afsar M; Kumar N; Kumar S; Ramachandran R
J Struct Biol; 2021 Mar; 213(1):107655. PubMed ID: 33197566
[TBL] [Abstract][Full Text] [Related]
28. Structure guided understanding of NAD+ recognition in bacterial DNA ligases.
Lahiri SD; Gu RF; Gao N; Karantzeni I; Walkup GK; Mills SD
ACS Chem Biol; 2012 Mar; 7(3):571-80. PubMed ID: 22230472
[TBL] [Abstract][Full Text] [Related]
29. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mimivirus NAD+-dependent DNA ligase.
Benarroch D; Shuman S
Virology; 2006 Sep; 353(1):133-43. PubMed ID: 16844179
[TBL] [Abstract][Full Text] [Related]
31. Human DNA ligases: a comprehensive new look for cancer therapy.
Singh DK; Krishna S; Chandra S; Shameem M; Deshmukh AL; Banerjee D
Med Res Rev; 2014 May; 34(3):567-95. PubMed ID: 23959747
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting NAD+-dependent DNA ligase activity with 2-(cyclopentyloxy)-5'-deoxyadenosine (CPOdA) offers a new tool for DNA replication and repair studies in the model archaeon Haloferax volcanii.
Giroux X; MacNeill SA
FEMS Microbiol Lett; 2015 Nov; 362(21):. PubMed ID: 26420852
[TBL] [Abstract][Full Text] [Related]
33. A high-throughput assay for the adenylation reaction of bacterial DNA ligase.
Miesel L; Kravec C; Xin AT; McMonagle P; Ma S; Pichardo J; Feld B; Barrabee E; Palermo R
Anal Biochem; 2007 Jul; 366(1):9-17. PubMed ID: 17493575
[TBL] [Abstract][Full Text] [Related]
34. AG205, a novel agent directed against FabK of Streptococcus pneumoniae.
Takahata S; Iida M; Osaki Y; Saito J; Kitagawa H; Ozawa T; Yoshida T; Hoshiko S
Antimicrob Agents Chemother; 2006 Aug; 50(8):2869-71. PubMed ID: 16870790
[TBL] [Abstract][Full Text] [Related]
35. Polyphosphate-containing bisubstrate analogues as inhibitors of a bacterial cell wall thymidylyltransferase.
Smithen DA; Forget SM; McCormick NE; Syvitski RT; Jakeman DL
Org Biomol Chem; 2015 Mar; 13(11):3347-50. PubMed ID: 25655582
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structural characterisation of selective non-carbohydrate-based inhibitors of bacterial sialidases.
Brear P; Telford J; Taylor GL; Westwood NJ
Chembiochem; 2012 Nov; 13(16):2374-83. PubMed ID: 23070966
[TBL] [Abstract][Full Text] [Related]
37. Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.
Spickenreither M; Braun S; Bernhardt G; Dove S; Buschauer A
Bioorg Med Chem Lett; 2006 Oct; 16(20):5313-6. PubMed ID: 16908142
[TBL] [Abstract][Full Text] [Related]
38. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole.
Rigden DJ; Botzki A; Nukui M; Mewbourne RB; Lamani E; Braun S; von Angerer E; Bernhardt G; Dove S; Buschauer A; Jedrzejas MJ
Glycobiology; 2006 Aug; 16(8):757-65. PubMed ID: 16638841
[TBL] [Abstract][Full Text] [Related]
39. Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK.
Ozawa T; Kitagawa H; Yamamoto Y; Takahata S; Iida M; Osaki Y; Yamada K
Bioorg Med Chem; 2007 Dec; 15(23):7325-36. PubMed ID: 17892940
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of human DNA ligase inhibitors using computer-aided drug design.
Zhong S; Chen X; Zhu X; Dziegielewska B; Bachman KE; Ellenberger T; Ballin JD; Wilson GM; Tomkinson AE; MacKerell AD
J Med Chem; 2008 Aug; 51(15):4553-62. PubMed ID: 18630893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
